On the fly News and insights, exclusive to thefly.com

NVAX

Novavax

$111.07 /

+1.115 (+1.01%)

, MRNA

Moderna

$80.23 /

+5.19 (+6.92%)

08:45
07/16/20
07/16
08:45
07/16/20
08:45

Novavax price target raised to $155 from $106 at B. Riley FBR

B. Riley FBR analyst Mayank Mamtani raised the firm's price target on Novavax (NVAX) to $155 from $106 and reiterates a Buy rating on the shares after hosting management for a virtual summit. The stock closed Wednesday at $111.15. With one week into the $1.6B Operation Warp Speed funding enabling availability of 100M NVX-CoV2373 doses by year-end, Novavax is "moving full speed ahead" towards unblinding of its ongoing Phase I 130-subject study, Mamtani tells investors in a research note. The analyst believes Novavax will preview the Phase I immunogenicity data by the end of July and that it is "likely to emerge as strongest among peers." Mamtani also believes the mRNA-1273 Phase I data from Moderna (MRNA) provides a favorable read-trough for Novavax.

NVAX

Novavax

$111.07 /

+1.115 (+1.01%)

MRNA

Moderna

$80.23 /

+5.19 (+6.92%)

  • 06

    Aug

  • 12

    Feb

  • 19

    May

NVAX Novavax
$111.07 /

+1.115 (+1.01%)

07/16/20 H.C. Wainwright
Novavax price target raised to $132 from $101 at H.C. Wainwright
07/08/20
Fly Intel: Top five analyst downgrades
07/08/20 Ladenburg
Novavax downgraded to Neutral from Buy at Ladenburg
07/07/20 Cantor Fitzgerald
Novavax price target raised to $148 from $88 at Cantor Fitzgerald
MRNA Moderna
$80.23 /

+5.19 (+6.92%)

07/15/20 JPMorgan
JPMorgan 'encouraged' by results of Moderna COVID vaccine candidate
07/15/20 Piper Sandler
Moderna price target raised to $134 from $100 at Piper Sandler
07/15/20 Goldman Sachs
Moderna Phase 1 COVID-19 vaccine data 'impresses,' says Goldman Sachs
07/14/20 Piper Sandler
Moderna COVID vaccine trial on track for July start, says Piper Sandler

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.